<?xml version="1.0" encoding="UTF-8"?>
<ref id="b13-1031835">
 <label>13.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Noguchi</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Nakaseko</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Nishiwaki</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan</article-title>. 
  <source>Int J Hematol</source>. 
  <year>2018</year>;
  <volume>108</volume>(
  <issue>2</issue>):
  <fpage>176</fpage>â€“
  <lpage>183</lpage>.
  <pub-id pub-id-type="pmid">29713954</pub-id>
 </mixed-citation>
</ref>
